{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:00:01Z","timestamp":1770382801573,"version":"3.49.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Postmenopausal osteoporosis (PMOP) is a bone metabolic disorder characterized by reduced bone mass and deterioration of bone microarchitecture, and its early diagnosis is essential for improving clinical outcomes. However, reliable biochemical markers for the early detection of PMOP remain unavailable in current practice. Macrophage migration inhibitory factor (MIF) is an inflammation-related protein with oxidoreductase-like activity that participates in bone remodeling and metabolic regulation Mainly by activating the NF-\u03baB signaling pathway. Nevertheless, its potential utility as a diagnostic compound in PMOP has not been fully clarified. The objective of this study was to investigate the plasma expression pattern of MIF in PMOP patients and explore its potential as an early diagnostic biomarker. Plasma MIF levels were significantly elevated in PMOP patients compared with individuals with normal bone mass (1.72\u00a0ng\/mL vs. 0.58\u00a0ng\/mL, p &amp;lt; 0.001). Moreover, MIF concentrations were negatively correlated with bone mineral density at the femoral neck (r = \u22120.548) and lumbar spine (r = \u22120.513), and positively correlated with bone turnover markers \u03b2-CTX (r = 0.417) and PINP (r = 0.350), suggesting that elevated MIF may reflect enhanced bone resorption and disruption of bone metabolic homeostasis. Further multivariate analyses identified MIF as an independent risk factor for PMOP and demonstrated its substantial diagnostic value. In conclusion, MIF,an inflammation-associated protein with oxidoreductase-like catalytic properties,may serve as a biochemical indicator of abnormal bone metabolism, providing a potential molecular basis for the early diagnosis of PMOP.<\/jats:p>","DOI":"10.3389\/fchem.2026.1780639","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:10:16Z","timestamp":1770333016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein compound macrophage migration inhibitory factor for diagnosing postmenopausal osteoporosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Chendi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fankai","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hehuan","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzhao","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengwei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, 5th Affiliated Hospital, Lishui Municipal Central Hospital, Wenzhou Medical College","place":["Lishui, China"]},{"name":"Department of Orthopedics, Lishui Municipal Central Hospital","place":["Lishui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-\u03baB signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteoporos. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.33594\/000000809","article-title":"Macrophage migration inhibitory factor: its multifaceted role in inflammation and immune regulation across organ systems","volume":"59","author":"Aliyarbayova","year":"2025","journal-title":"Cell Physiol. Biochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/35046196","article-title":"Bone versus immune system","volume":"408","author":"Arron","year":"2000","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/postgradmedj-2017-134934","article-title":"Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis","volume":"94","author":"Bae","year":"2018","journal-title":"Postgrad. Med. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"14144","DOI":"10.1021\/bi00251a025","article-title":"Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)","volume":"33","author":"Bernhagen","year":"1994","journal-title":"Biochemistry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/pgmj.2007.057505","article-title":"The role of DXA bone density scans in the diagnosis and treatment of osteoporosis","volume":"83","author":"Blake","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100190","DOI":"10.1016\/j.bonr.2018.100190","article-title":"Longitudinal changes in bone mineral density, bone mineral content and bone area at the lumbar spine and hip in postmenopausal women, and the influence of abdominal aortic calcification","volume":"10","author":"Bristow","year":"2019","journal-title":"Bone Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3892\/ijmm.2025.5590","article-title":"Macrophage migration inhibitory factor: exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks","volume":"56","author":"Camacho Meza","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/s2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s11136-022-03281-1","article-title":"Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis","volume":"32","author":"Gao","year":"2023","journal-title":"Qual. Life Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1359\/jbmr.1997.12.8.1280","article-title":"Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The international quantitative ultrasound consensus group","volume":"12","author":"Gl\u00fcer","year":"1997","journal-title":"J. Bone Min. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cyto.2014.11.015","article-title":"Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis","volume":"72","author":"Gu","year":"2015","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jare.2023.01.003","article-title":"Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss","volume":"53","author":"He","year":"2023","journal-title":"J. Adv. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the european union: medical management, epidemiology and economic burden","volume":"8","author":"Hernlund","year":"2013","journal-title":"Archives Osteoporos."},{"key":"B18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0004563213515190","article-title":"Biochemical markers of bone turnover - uses and limitations","volume":"51","author":"Hlaing","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"114734","DOI":"10.1016\/j.bcp.2021.114734","article-title":"Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-\u03baB signaling pathway","volume":"192","author":"Jin","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/bf01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos. Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3803\/EnM.2016.31.3.454","article-title":"The association of higher plasma macrophage migration inhibitory factor levels with lower bone mineral density and higher bone turnover rate in postmenopausal women","volume":"31","author":"Kim","year":"2016","journal-title":"Endocrinol. Metab. Seoul."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00198-010-1385-0","article-title":"Impaired fracture healing in macrophage migration inhibitory factor-deficient mice","volume":"22","author":"Kobayashi","year":"2011","journal-title":"Osteoporos. Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11914-010-0004-5","article-title":"Benefits and limitations of bone mineral density and bone turnover markers to monitor patients treated for osteoporosis","volume":"8","author":"Lewiecki","year":"2010","journal-title":"Curr. Osteoporos. Rep."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.16966\/2472-6990.119","article-title":"MIF promotes bone defect repair by regulating macrophages","volume":"3","author":"Li","year":"2018","journal-title":"Cell, Stem Cells Regen. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"117331","DOI":"10.1016\/j.bone.2024.117331","article-title":"Macrophage migration inhibitory factor promotes heterotopic ossification by mediating ROS\/HIF-1\u03b1 positive feedback loop and activating Wnt\/\u03b2-catenin signaling pathway","volume":"190","author":"Li","year":"2025","journal-title":"Bone"},{"key":"B27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41514-025-00269-2","article-title":"Global epidemiology and burden of osteoporosis among postmenopausal women: insights from the global burden of disease study 2021","volume":"11","author":"Liang","year":"2025","journal-title":"NPJ Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiol.2633201203","article-title":"Osteoporosis imaging: state of the art and advanced imaging","volume":"263","author":"Link","year":"2012","journal-title":"Radiology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s12325-019-01063-9","article-title":"Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and Follow-Up of treatment for osteoporosis","volume":"36","author":"Lorentzon","year":"2019","journal-title":"Adv. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s1286-4579(02)01560-5","article-title":"Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease","volume":"4","author":"Lue","year":"2002","journal-title":"Microbes Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2147\/cia.S170111","article-title":"Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis","volume":"13","author":"Mederle","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin","year":"2025","journal-title":"Jama"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jbmr.2854","article-title":"Macrophage migration inhibitory factor (MIF) supports homing of osteoclast precursors to peripheral osteolytic lesions","volume":"31","author":"Movila","year":"2016","journal-title":"J. Bone Min. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1359\/jbmr.060310","article-title":"Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis","volume":"21","author":"Onodera","year":"2006","journal-title":"J. Bone Min. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrrheum.2017.91","article-title":"MIF drives inflammation and bone formation in AS","volume":"13","author":"Onuora","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.febslet.2006.01.038","article-title":"Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss","volume":"580","author":"Oshima","year":"2006","journal-title":"FEBS Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e38694","DOI":"10.1371\/journal.pone.0038694","article-title":"Constitutively active canonical NF-\u03baB pathway induces severe bone loss in mice","volume":"7","author":"Otero","year":"2012","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/nejm198411153112002","article-title":"Relative contributions of aging and estrogen deficiency to postmenopausal bone loss","volume":"311","author":"Richelson","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00198-010-1242-1","article-title":"Microarchitecture in focus","volume":"21","author":"Rizzoli","year":"2010","journal-title":"Osteoporos. Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"h5746","DOI":"10.1136\/bmj.h5746","article-title":"Diagnosis and management of menopause: summary of NICE guidance","volume":"351","author":"Sarri","year":"2015","journal-title":"Bmj"},{"key":"B42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.redox.2017.11.028","article-title":"Post-translational regulation of macrophage migration inhibitory factor: basis for functional fine-tuning","volume":"15","author":"Schindler","year":"2018","journal-title":"Redox Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"882241","DOI":"10.3389\/fendo.2022.882241","article-title":"The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"109600","DOI":"10.1016\/j.intimp.2022.109600","article-title":"Macrophage migration inhibitory factor (MIF) inhibitor iSO-1 promotes staphylococcal protein A-induced osteogenic differentiation by inhibiting NF-\u03baB signaling pathway","volume":"115","author":"Shi","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2013.05.018","article-title":"Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels","volume":"63","author":"Sobierajski","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"S\u00f6zen","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.pharmthera.2021.108024","article-title":"Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bone.2010.05.009","article-title":"Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women","volume":"47","author":"Swanberg","year":"2010","journal-title":"Bone"},{"key":"B49","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1636839","DOI":"10.3389\/fimmu.2025.1636839","article-title":"Macrophage migration inhibitory factor (MIF) and the tumor ecosystem: a tale of inflammation, immune escape, and tumor growth","volume":"16","author":"Youness","year":"2025","journal-title":"Front. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.1096\/fj.201802364RR","article-title":"Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-\u03baB signaling pathway","volume":"33","author":"Zheng","year":"2019","journal-title":"Faseb J."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1780639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:10:17Z","timestamp":1770333017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1780639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":53,"alternative-id":["10.3389\/fchem.2026.1780639"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1780639","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"article-number":"1780639"}}